{"chunk_id": "medquad__chunk_24399", "source": "medquad", "text": "the effectiveness of DBS is currently underway. Recently, interest in chelating agents (agents that remove iron from the body) has also been revived, although the benefits have not yet been documented and systemic anemia remains a risk. A trial using deferriprone (a chelator) in PKAN is currently underway in Italy. Click on the link to learn more about this study.\",GARD,Pantothenate kinase-associated neurodegeneration\nWhat are the symptoms of Chromosome 17q11.2 deletion syndrome ?,\"What are the"}